For decades, transvaginal mesh has been surgically implanted in women across the nation and world to treat organ prolapse and urinary incontinence. For some women, the plastic medical device was helpful. But for tens of thousands – far too high a percentage for the vaginal mesh products to be considered safe -- the mesh eroded after it was implanted. Subsequent surgeries were unsuccessful in removing these “shards.” Women were left in severe pain, particularly when trying to have sexual intercourse, a condition known as dyspareunia.
The recent $57.1 million verdict against Johnson & Johnson over its defective vaginal mesh devices did more than produce a large award for a plaintiff who suffered permanent injury. It also raised awareness among many more women across the country who may endure permanent and severe pain as a result of having the products surgically implanted.